Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CLINICAL MEASUREMENT - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).

Term:percentage of study population developing T-cell lymphomas during a period of time
go back to main search page
Accession:CMO:0001911 term browser browse the term
Definition:The number of new cases of T-cell lymphoma appearing in a study population during a certain period compared to the total number of individuals in the study population, expressed as a percentage. T-cell lymphoma refers to a heterogeneous group of usually malignant lymphoid neoplasms that occur as circumscribed solid tumors and that are composed of T lymphocytes. T lymphocytes are white blood cells that complete maturation in the thymus and that have various roles in the immune system, including the identification of specific foreign antigens in the body, the mediation of cellular immune responses, and the activation and deactivation of other immune cells.
Synonyms:related_synonym: T-cell lymphoma incidence



show annotations for term's descendants           Sort by:

Term paths to the root
Path 1
Term Annotations click to browse term
  clinical measurement 0
    disease population measurement 0
      disease incidence/prevalence measurement 0
        lymphoma incidence/prevalence measurement 0
          T-cell lymphoma incidence/prevalence measurement 0
            percentage of study population developing T-cell lymphomas during a period of time 0
Path 2
Term Annotations click to browse term
  clinical measurement 0
    organ measurement 0
      organ lesion measurement 0
        organ tumorous lesion measurement 0
          organ tumorous lesion incidence/prevalence measurement 0
            tumor incidence/prevalence measurement 0
              lymphoma incidence/prevalence measurement 0
                T-cell lymphoma incidence/prevalence measurement 0
                  percentage of study population developing T-cell lymphomas during a period of time 0
paths to the root